NCT06411743 - Phase II/III of Recombinant Human Albumin Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 7, 2021

Primary Completion Date

August 15, 2022

Study Completion Date

August 15, 2022

Conditions

Hepatic Ascites

Interventions

BIOLOGICAL

Recombinant Human Albumin Injection

Recombinant Human Albumin injection, strength: 10 g/vial (20%, 50 mL); storage conditions: 2-8°C, protected from light; manufactured and supplied by Tonghua Anrate Biopharmaceutical Co., Ltd.

BIOLOGICAL

Human Albumin

Human Albumin (An Pu Lai Shi®), strength: 10 g/vial (protein concentration 20%, 50 mL/vial), storage conditions: 2-8°C, protected from light; manufactured by Shanghai RAAS Blood Products Co., Ltd.

Trial Locations (1)

130021

The First Hospital of Jilin University (Leading Site), Changchun

All Listed Sponsors

lead

The First Hospital of Jilin University

OTHER